Treatment for DNA Damage

University of New Mexico Health Sciences Center, Albuquerque, NM
DNA Damage+1 More Conditions
Eligibility
21 - 64
All Sexes

Study Summary

This trial will study if zinc supplements can help reduce the harmful effects of metal exposure in Indigenous populations.

Eligible Conditions
  • DNA Damage
  • Immune Disorders

Treatment Effectiveness

Phase-Based Effectiveness

1 of 3
N/A

Study Objectives

4 Primary · 2 Secondary · Reporting Duration: Visit 1 (0 months-baseline 1), Visit 2 (3 months-baseline 2), Visit 3 (6 months-zinc 1), Visit 4 (9 months-zinc 2)

Month 9
Autoantibody measurement to compare change from baseline versus zinc supplement
Cytokine level measurement to compare change from baseline versus zinc supplement
DNA damage assays to compare change from baseline versus zinc supplement
Lymphocyte phenotyping to compare change from baseline versus zinc supplement
Metal biomonitoring to compare change from baseline versus zinc supplement
PARP activity assays to compare change from baseline versus zinc supplement
Month 9
Exploratory outcome dietary nutritional intake

Trial Safety

Awards & Highlights

No Placebo Group
All patients enrolled in this trial will receive the new treatment.

Trial Design

0 Treatment Group

100 Total Participants · 0 Treatment Group

Primary Treatment: Treatment · No Placebo Group · N/A

Trial Logistics

Trial Timeline

Screening: ~3 weeks
Treatment: Varies
Reporting: visit 1 (0 months-baseline 1), visit 2 (3 months-baseline 2), visit 3 (6 months-zinc 1), visit 4 (9 months-zinc 2)

Who is running the clinical trial?

University of New MexicoLead Sponsor
348 Previous Clinical Trials
3,539,343 Total Patients Enrolled

Eligibility Criteria

Age 21 - 64 · All Participants · 1 Total Inclusion Criteria

Mark “Yes” if the following statements are true for you:
You are okay with taking a zinc supplement every day.

Frequently Asked Questions

What criteria must be met to qualify for participation in this trial?

"This trial seeks 100 volunteers aged 21 to 64 who suffer from an immunological disorder. Eligibility is centered around two parameters: residence in either Blue Gap-Tachee, Arizona or Red Water Pond Road Community, New Mexico; and a willingness to attend study visits on prearranged dates." - Anonymous Online Contributor

Unverified Answer

How many participants are being enrolled for this research initiative?

"Affirmative. According to the clinicaltrials.gov registry, this medical trial is actively recruiting participants since its inception on May 19th 2019 and latest update on July 25th 2022. A total of 100 volunteers are needed at a single site for enrollment in the study." - Anonymous Online Contributor

Unverified Answer

Does this research trial include participants of forty years and above?

"This clinical trial is seeking volunteers who are between the ages of 21 and 64." - Anonymous Online Contributor

Unverified Answer

Is there an ongoing opportunity to join this medical trial?

"Affirmative. The clinicaltrials.gov website reveals that this experiment, which was initiated on the 19th of May 2019 is currently enrolling patients. To be exact, 100 participants must be sourced from a single location for the trial to progress." - Anonymous Online Contributor

Unverified Answer

Are there reputable studies that have evaluated the efficacy of this therapeutic approach?

"Currently, one research study involving this treatment is being conducted in real-world settings. There are no Phase 3 trials at the moment and all of them take place in Albuquerque, New Mexico." - Anonymous Online Contributor

Unverified Answer
Please Note: These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.